genomic profiling of hr /her2- breast cancer and brain metastases
Published 5 months ago • 114 plays • Length 3:10Download video MP4
Download video MP3
Similar videos
-
1:35
gene expression profiling of breast cancer brain mets shows enrichment for non-luminal subtypes
-
1:22
genomic profiling in her2 disease
-
3:15
brain metastases in her2 breast cancer
-
1:05
the genomic characterization of primary and metastatic her2-low breast cancers
-
1:33
destiny-breast12: enhancing outcomes for hr /her2 patients with brain metastases
-
2:14
survival in premenopausal hr /her2- breast cancer with micro-metastasis and 21-gene score
-
2:33
her2climb: tucatinib with trastuzumab and capecitabine for her2 breast cancer with brain metastases
-
1:29
tuxedo-1: trastuzumab deruxtecan for the treatment of her2-positive breast cancer brain metastases
-
5:37
therapeutic landscape for patients with her2-positive breast cancer with active brain metastases
-
2:09
the evolution of her2 targeting in metastatic breast breast cancer
-
1:26
genomic and transcriptomic landscape of her2-low breast cancer
-
2:11
her2 in prognosis of brain metastasis in breast cancer
-
0:53
tuxedo-1: t-dxd for patients with her2-positive breast cancer and brain metastasis
-
0:53
the latest news on the management of breast cancer patients with brain metastases
-
5:55
decision-making in metastatic her2 breast cancer
-
1:56
treating her2 breast cancer with brain metastases
-
1:24
potential treatment approaches for breast cancer with brain metastases
-
0:54
treatment de-escalation in premenopausal patients with hr /her2- breast cancer and micro-metastasis
-
0:44
across-trop2: identifying predictive biomarkers of sg in hr /her2- breast cancer